Key Benefits:

• High purity (claimed 99.8%) for reduced risk of impurities and consistent performance.

• Rapid onset of visible improvement (typically 3–7 days).

• Broad clinical utility: aesthetic wrinkle correction and therapeutic indications.

• Preserves natural facial expression while reducing muscle overactivity.

Effects:

• Smoothes forehead lines, glabellar (frown) lines, crow’s feet and other dynamic wrinkles.

• Improves skin surface appearance by relaxing muscles that cause expression lines.

• Can reduce excessive sweating (hyperhidrosis) and relieve blepharospasm where indicated.

Duration:

• Results typically become apparent within 3–7 days; clinical effect commonly persists for approximately 4–6 months depending on patient factors and treatment area.

Composition & Packaging:

• Main Ingredient: Clostridium Botulinum Toxin Type A (strain CBFC26).

• Packing Unit: 1 vial containing 200 units.

• Form: Lyophilized powder for reconstitution (supplied as a sealed glass vial).

Contraindications & Precautions:

• Contraindicated in patients with known hypersensitivity to botulinum toxin or any component of the formulation.

• Not for use where infection or inflammation is present at the injection site.

• Caution in patients with neuromuscular disorders, respiratory compromise, bleeding disorders, or concurrent use of certain antibiotics that may potentiate effects.

• Not recommended for use during pregnancy or breastfeeding.

• Administration and dosing must be determined and performed by qualified medical professionals.

Liztox 200 Units provides a high-purity neuromodulator option for clinicians seeking rapid, predictable wrinkle reduction and selected therapeutic applications while maintaining natural facial movement.